A cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer ...

The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...

The AstraZeneca PLC ADR AZN slipped 1.58% to $77.14 Monday, on what proved to be an all-around great trading session for the ...

We recently compiled a list of the 10 Best Growth Stocks To Buy According To George Soros. In this article, we will look at ...

AstraZeneca PLC AZN shares dropped 1.66% to £115.84 Monday, on what proved to be an all-around great trading session for the ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second quarter 2024 ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

Intel jumps on reports of Apollo investment and Qualcomm takeover interest, Palantir and Dell join the S&P 500, and TSMC and Samsung reportedly mulling UAE chip megafactories. Here's what investors ...

Pondy Oxides and Chemicals, Thangamayil Jewellery, Power Grid Corporation of India, Cubex Tubings, G R Infraprojects, Western ...

REA’s new Rightmove proposal is an increase of 9.2% on its 5 September approach and a rise of 39% on the position of the FTSE ...

European shares started Monday on a subdued note as investors maintained a cautious stance ahead of a slew of key economic ...